Complete Filing Data
Benitec Biopharma Inc. reported Stockholders Equity of $202.0 thousand for FY2023.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Benitec Biopharma Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue * | $0.00 | $75.0K | $73.0K | $59.0K | $97.0K | $11.6M | |
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | $53.0K | -$62.0K | $415.0K | $210.0K | $498.0K | -$89.0K | -$531.0K |
| Net Income Loss | -$37.9M | -$21.8M | -$19.6M | -$18.2M | -$13.9M | -$8.3M | $2.6M |
| Research And Development Expense | $18.3M | $15.6M | $12.8M | $11.3M | $7.0M | $3.0M | $4.6M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $53.0K | -$62.0K | $415.0K | $210.0K | $498.0K | -$89.0K | -$531.0K |
| Operating Income Loss | -$41.8M | -$22.5M | -$19.1M | -$17.9M | -$13.6M | -$8.3M | $2.6M |
| Operating Expenses | $41.8M | $22.5M | $19.2M | $17.9M | $13.7M | $8.4M | $9.6M |
| Nonoperating Income Expense | $3.8M | $739.0K | -$481.0K | -$354.0K | -$286.0K | $7.0K | $26.0K |
| Interest Income Expense Nonoperating Net | $3.3M | $904.0K | -$33.0K | -$32.0K | -$6.0K | $62.0K | $122.0K |
| General And Administrative Expense | $23.4M | $7.0M | $6.4M | $6.6M | $6.5M | $5.6M | $4.6M |
| Comprehensive Income Net Of Tax | -$37.9M | -$21.8M | -$19.1M | -$18.0M | -$13.4M | -$8.4M | $2.1M |
| Other Nonoperating Income Expense | -$131.0K | -$204.0K | -$30.0K | -$79.0K | $37.0K | $34.0K | |
| Net Income Loss Available To Common Stockholders Basic | -$37.9M | -$22.4M | -$19.6M | ||||
| Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount | $0.00 | $619.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue * | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $54.0K | $14.0K | $0.00 | $48.0K | $25.0K | $0.00 | $1.0K | $1.0K | $55.0K | $28.0K | $77.0K | $33.0K | |
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | -$133.0K | $89.0K | -$123.0K | -$28.0K | $305.0K | -$101.0K | $117.0K | -$172.0K | $50.0K | $45.0K | -$160.0K | $507.0K | -$233.0K | -$57.0K | $239.0K | -$24.0K | $208.0K | $178.0K | -$901.0K | $336.0K | -$304.0K |
| Net Income Loss | -$11.8M | -$9.0M | -$8.8M | -$9.4M | -$9.6M | -$5.1M | -$4.3M | -$6.8M | -$6.0M | -$4.4M | -$5.4M | -$5.1M | -$3.3M | -$4.8M | -$5.0M | -$3.9M | -$3.3M | -$2.7M | -$2.1M | -$2.1M | -$1.1M |
| Research And Development Expense | $5.8M | $3.4M | $2.9M | $6.0M | $5.4M | $3.6M | $2.6M | $5.1M | $4.4M | $3.2M | $3.8M | $2.7M | $2.2M | $3.1M | $2.8M | $2.8M | $1.2M | $774.0K | $805.0K | $599.0K | $423.0K |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$133.0K | $89.0K | -$123.0K | -$28.0K | $305.0K | -$101.0K | $117.0K | -$172.0K | $50.0K | $45.0K | -$160.0K | $507.0K | -$233.0K | -$57.0K | $239.0K | -$24.0K | $208.0K | $178.0K | -$901.0K | $336.0K | -$304.0K |
| Operating Income Loss | -$13.4M | -$9.8M | -$9.8M | -$10.2M | -$10.8M | -$5.8M | -$4.1M | -$6.9M | -$5.9M | -$4.3M | -$5.6M | -$4.6M | -$3.5M | -$4.8M | -$4.8M | -$3.8M | -$3.3M | -$2.7M | -$2.1M | -$2.1M | -$1.2M |
| Operating Expenses | $13.4M | $9.8M | $9.8M | $10.2M | $10.8M | $5.8M | $4.1M | $6.9M | $5.9M | $4.4M | $5.6M | $4.6M | $3.5M | $4.9M | $4.8M | $3.8M | $3.3M | $2.7M | $2.1M | $2.2M | $1.2M |
| Nonoperating Income Expense | $1.5M | $838.0K | $1.0M | $834.0K | $1.3M | $732.0K | -$138.0K | $129.0K | -$80.0K | -$56.0K | $199.0K | -$513.0K | $185.0K | $14.0K | -$223.0K | -$116.0K | $7.0K | -$28.0K | $9.0K | $21.0K | $19.0K |
| Interest Income Expense Nonoperating Net | $1.4M | $1.0M | $1.0M | $823.0K | $823.0K | $604.0K | -$4.0K | -$6.0K | -$6.0K | -$7.0K | -$9.0K | -$9.0K | -$10.0K | -$11.0K | -$1.0K | -$2.0K | -$2.0K | -$1.0K | $16.0K | $17.0K | $18.0K |
| General And Administrative Expense | $7.5M | $6.4M | $7.0M | $4.2M | $5.4M | $2.2M | $1.6M | $1.8M | $1.6M | $1.2M | $1.9M | $1.9M | $1.3M | $1.7M | $2.0M | $1.0M | $2.1M | $1.8M | $1.3M | $1.9M | $750.0K |
| Comprehensive Income Net Of Tax | -$12.0M | -$8.9M | -$8.9M | -$9.4M | -$9.2M | -$5.2M | -$4.2M | -$7.0M | -$5.9M | -$4.4M | -$5.6M | -$4.6M | -$3.5M | -$4.9M | -$4.8M | -$3.9M | -$3.0M | -$2.5M | -$3.0M | -$1.8M | -$1.5M |
| Other Nonoperating Income Expense | $19.0K | -$84.0K | -$126.0K | $0.00 | -$40.0K | $35.0K | -$16.0K | -$16.0K | -$18.0K | $0.00 | $50.0K | $0.00 | -$29.0K | $0.00 | $0.00 | $10.0K | $27.0K | ||||
| Net Income Loss Available To Common Stockholders Basic | -$11.8M | -$9.0M | -$9.4M | -$9.6M | -$5.1M | -$4.3M | -$6.8M | -$6.6M | |||||||||||||
| Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $619.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $202.0K | $2.9M | $20.0M | $10.2M | $16.6M | $13.8M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.5M | $4.1M | $19.8M | $9.8M | ||||
| Unrealized Gain Loss On Investments | $0.00 | -$1.0K | -$3.0K | -$11.0K | $16.0K | -$1.0K | -$21.0K | |
| Cash And Cash Equivalents At Carrying Value | $50.9M | $2.5M | $4.1M | $19.8M | $15.7M | $11.9M | ||
| Retained Earnings Accumulated Deficit | -$190.3M | -$181.3M | -$148.3M | -$130.1M | -$116.6M | -$108.9M | ||
| Additional Paid In Capital Common Stock | $238.4M | $197.7M | $152.5M | $151.6M | $128.8M | $127.3M | ||
| Operating Lease Right Of Use Asset | $270.0K | $526.0K | $771.0K | $771.0K | $395.0K | |||
| Property Plant And Equipment Net | $179.0K | $87.0K | $222.0K | $375.0K | $374.0K | $470.0K | ||
| Liabilities Current | $4.9M | $4.0M | $2.5M | $1.4M | $1.1M | $2.6M | ||
| Liabilities And Stockholders Equity | $52.2M | $4.5M | $6.0M | $21.4M | $11.6M | $19.2M | ||
| Liabilities | $5.0M | $4.3M | $3.1M | $1.4M | $1.3M | $2.6M | ||
| Increasedecrease In Accounts And Other Payables | -$2.4M | $941.0K | $1.4M | $1.1M | $55.0K | -$1.7M | $740.0K | |
| Employee Related Liabilities Current | $475.0K | $472.0K | $400.0K | $276.0K | $203.0K | $147.0K | ||
| Deposit Assets | $25.0K | $25.0K | $25.0K | $9.0K | $9.0K | $9.0K | ||
| Common Stock Value | $1.0K | $0.00 | $0.00 | $1.0K | $0.00 | $1.0K | ||
| Assets Current | $51.7M | $3.7M | $4.8M | $20.6M | $10.8M | $18.8M | ||
| Assets | $52.2M | $4.5M | $6.0M | $21.4M | $11.6M | $19.2M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$892.0K | -$830.0K | -$1.2M | -$1.5M | -$2.0M | -$1.9M | ||
| Accounts Payable And Other Accrued Liabilities Current | $4.2M | $3.2M | $1.9M | $880.0K | $741.0K | $2.5M | ||
| Accounts And Other Receivables Net Current | $229.0K | $55.0K | $3.0K | $25.0K | $59.0K | $2.5M | ||
| Operating Lease Liability Current | $284.0K | $275.0K | $252.0K | $213.0K | $192.0K | |||
| Amortization Of Right Of Use Assets | $330.0K | $256.0K | $245.0K | $225.0K | $193.0K | $184.0K | ||
| Operating Lease Liability Noncurrent | $0.00 | $284.0K | $559.0K | $213.0K | ||||
| Prepaid Expense And Other Assets Current | $516.0K | $1.2M | $741.0K | $799.0K | $949.0K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $46.9M | $48.4M | -$1.6M | -$15.7M | $10.0M | |||
| Restricted Cash Current | $63.0K | $13.0K | $14.0K | $15.0K | ||||
| Prepaid Expense And Other Assets Noncurrent | $62.0K | $97.0K | $135.0K | |||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $794.0K | $0.00 | $579.0K | ||||
| Gains Losses On Extinguishment Of Debt | $764.0K | $0.00 | ||||||
| Other Assets Noncurrent | $185.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $187.4M | $93.6M | $97.3M | $97.6M | $75.9M | $64.2M | $47.2M | $11.5M | $15.5M | $22.3M | $4.7M | $9.0M | $14.6M | $7.5M | $10.8M | $15.5M | $10.9M | $14.6M | $7.7M | $12.3M | $15.3M | $17.0M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $188.9M | $94.6M | $97.9M | $103.6M | $78.3M | $67.9M | $50.9M | $14.2M | $20.4M | $25.9M | $6.6M | $10.6M | $16.5M | $8.6M | $12.3M | $15.7M | $12.0M | ||||||||
| Unrealized Gain Loss On Investments | $0.00 | $0.00 | $0.00 | -$1.0K | $0.00 | -$4.0K | -$3.0K | $3.0K | -$5.0K | -$23.0K | $18.0K | -$2.0K | -$1.0K | $0.00 | -$1.0K | $1.0K | |||||||||
| Cash And Cash Equivalents At Carrying Value | $188.8M | $94.5M | $97.7M | $103.6M | $78.3M | $67.8M | $20.4M | $25.9M | $6.6M | $10.5M | $16.5M | $8.6M | $12.3M | $15.7M | $12.0M | $14.0M | $7.5M | $9.8M | $11.4M | $13.8M | $16.6M | ||||
| Retained Earnings Accumulated Deficit | -$249.0M | -$237.1M | -$228.2M | -$212.0M | -$202.7M | -$195.3M | -$163.2M | -$158.8M | -$153.4M | -$143.3M | -$140.0M | -$135.2M | -$126.1M | -$122.2M | -$119.3M | ||||||||||
| Additional Paid In Capital Common Stock | $437.2M | $331.5M | $326.3M | $310.3M | $279.3M | $260.5M | $168.8M | $168.7M | $168.8M | $152.3M | $152.1M | $151.9M | $138.6M | $138.4M | $128.9M | ||||||||||
| Operating Lease Right Of Use Asset | $905.0K | $755.0K | $860.0K | $964.0K | $137.0K | $204.0K | $335.0K | $400.0K | $463.0K | $589.0K | $650.0K | $711.0K | $828.0K | $888.0K | $947.0K | $252.0K | $300.0K | $348.0K | |||||||
| Property Plant And Equipment Net | $115.0K | $118.0K | $131.0K | $145.0K | $151.0K | $154.0K | $204.0K | $51.0K | $68.0K | $106.0K | $139.0K | $179.0K | $214.0K | $268.0K | $323.0K | $563.0K | $610.0K | $503.0K | |||||||
| Liabilities Current | $2.8M | $2.0M | $1.8M | $7.0M | $3.1M | $4.6M | $3.4M | $5.7M | $4.5M | $3.2M | $2.5M | $3.0M | $1.9M | $2.5M | $1.6M | $2.4M | $779.0K | $1.0M | |||||||
| Liabilities And Stockholders Equity | $190.7M | $96.0M | $99.6M | $105.2M | $79.1M | $68.8M | $15.0M | $21.4M | $27.1M | $8.2M | $11.9M | $18.1M | $10.1M | $14.0M | $17.8M | $13.4M | $15.5M | $8.9M | |||||||
| Liabilities | $3.3M | $2.4M | $2.3M | $7.6M | $3.1M | $4.6M | $3.5M | $5.9M | $4.7M | $3.5M | $2.9M | $3.5M | $2.5M | $3.2M | $2.4M | $2.5M | $887.0K | $1.2M | |||||||
| Increasedecrease In Accounts And Other Payables | $125.0K | -$322.0K | $566.0K | $500.0K | $293.0K | -$119.0K | -$645.0K | ||||||||||||||||||
| Employee Related Liabilities Current | $483.0K | $463.0K | $426.0K | $426.0K | $537.0K | $495.0K | $517.0K | $523.0K | $460.0K | $429.0K | $396.0K | $385.0K | $357.0K | $321.0K | $301.0K | $231.0K | $221.0K | $197.0K | |||||||
| Deposit Assets | $55.0K | $55.0K | $55.0K | $55.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $9.0K | $9.0K | $9.0K | |||||||
| Common Stock Value | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $0.00 | $0.00 | $0.00 | $3.0K | $3.0K | $3.0K | $1.0K | $1.0K | $1.0K | $5.0K | $4.0K | $1.0K | |||||||
| Assets Current | $189.6M | $95.1M | $98.5M | $104.0M | $78.7M | $68.3M | $14.4M | $20.8M | $26.4M | $7.4M | $11.0M | $17.1M | $8.8M | $12.7M | $16.4M | $12.4M | $14.4M | $8.1M | |||||||
| Assets | $190.7M | $96.0M | $99.6M | $105.2M | $79.1M | $68.8M | $15.0M | $21.4M | $27.1M | $8.2M | $11.9M | $18.1M | $10.1M | $14.0M | $17.8M | $13.4M | $15.5M | $8.9M | |||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$883.0K | -$750.0K | -$839.0K | -$716.0K | -$688.0K | -$993.0K | -$835.0K | -$952.0K | -$780.0K | -$853.0K | -$898.0K | -$738.0K | -$1.5M | -$1.3M | -$1.2M | -$1.6M | -$1.6M | -$1.8M | |||||||
| Accounts Payable And Other Accrued Liabilities Current | $1.9M | $1.1M | $1.0M | $6.3M | $2.4M | $3.8M | $2.6M | $4.9M | $3.8M | $2.5M | $1.8M | $2.4M | $1.3M | $1.9M | $1.1M | $2.0M | $355.0K | $624.0K | |||||||
| Accounts And Other Receivables Net Current | $130.0K | $7.0K | $33.0K | $3.0K | $2.0K | $4.0K | $53.0K | $53.0K | $53.0K | $56.0K | $68.0K | $3.0K | $5.0K | $5.0K | $3.0K | $10.0K | $21.0K | $18.0K | |||||||
| Operating Lease Liability Current | $468.0K | $414.0K | $354.0K | $346.0K | $137.0K | $211.0K | $292.0K | $286.0K | $280.0K | $269.0K | $263.0K | $258.0K | $232.0K | $213.0K | $194.0K | $208.0K | $203.0K | $198.0K | |||||||
| Amortization Of Right Of Use Assets | $105.0K | $66.0K | $63.0K | $60.0K | $50.0K | $47.0K | $46.0K | ||||||||||||||||||
| Operating Lease Liability Noncurrent | $519.0K | $403.0K | $495.0K | $613.0K | $62.0K | $137.0K | $211.0K | $354.0K | $422.0K | $491.0K | $635.0K | $698.0K | $760.0K | $0.00 | $54.0K | $108.0K | $161.0K | ||||||||
| Prepaid Expense And Other Assets Current | $562.0K | $480.0K | $628.0K | $361.0K | $366.0K | $426.0K | $157.0K | $355.0K | $482.0K | $774.0K | $356.0K | $531.0K | $206.0K | $338.0K | $642.0K | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$3.3M | $17.0M | $23.4M | $12.5M | -$4.0M | -$2.4M | |||||||||||||||||||
| Restricted Cash Current | $113.0K | $113.0K | $113.0K | $63.0K | $62.0K | $64.0K | $13.0K | $14.0K | $13.0K | $14.0K | $14.0K | $13.0K | |||||||||||||
| Prepaid Expense And Other Assets Noncurrent | $11.0K | $20.0K | $28.0K | $35.0K | $42.0K | $56.0K | $69.0K | $81.0K | $85.0K | ||||||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $794.0K | $0.00 | $579.0K | |||||||||||||||||||||
| Gains Losses On Extinguishment Of Debt | $0.00 | $0.00 | $0.00 | $764.0K | $0.00 | $0.00 | $0.00 | ||||||||||||||||||
| Other Assets Noncurrent | $105.0K | $116.0K | $119.0K | $135.0K | $156.0K | $161.0K | $169.0K | $197.0K | $210.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $66.0K | $87.0K | $136.0K | $167.0K | $231.0K | $190.0K | $158.0K |
| Payments Of Stock Issuance Costs | $2.3M | $5.9M | $1.9M | $3.2M | $480.0K | ||
| Share Based Compensation | $17.4M | $830.0K | $452.0K | $870.0K | $634.0K | $237.0K | $672.0K |
| Net Cash Provided By Used In Operating Activities | -$23.6M | -$19.4M | -$18.0M | -$15.9M | -$12.8M | -$7.5M | $4.8M |
| Increase Decrease In Lease Liabilities | -$356.0K | -$275.0K | -$252.0K | -$196.0K | -$192.0K | -$174.0K | |
| Increase Decrease In Employee Related Liabilities | -$81.0K | $39.0K | $73.0K | $80.0K | $121.0K | $57.0K | -$15.0K |
| Increase Decrease In Accounts And Other Receivables | -$197.0K | $176.0K | $50.0K | -$1.0K | -$28.0K | -$2.4M | -$607.0K |
| Net Cash Provided By Used In Investing Activities | -$18.0K | -$179.0K | -$1.0K | -$13.0K | -$221.0K | -$94.0K | -$400.0K |
| Net Cash Provided By Used In Financing Activities | $70.5M | $68.0M | $16.0M | $22.5M | $1.8M | ||
| Payments To Acquire Property Plant And Equipment | $18.0K | $179.0K | $1.0K | $13.0K | $221.0K | $95.0K | $404.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $49.0K | -$8.0K | $412.0K | $204.0K | $499.0K | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $111.0K | -$645.0K | $414.0K | -$62.0K | $4.0K | $457.0K | |
| Proceeds From Issuance Of Common Stock | $17.9M | $25.8M | $2.3M | ||||
| Increase Decrease In Other Operating Assets | $457.0K | $9.0K | |||||
| Proceeds From Issuance Of Common Stock Pre Funded Warrants And Common Warrants | $30.5M | $70.9M | $17.9M | ||||
| Effect Of Exchange Rate On Cash And Cash Equivalents | $499.0K | -$58.0K | -$551.0K | ||||
| Proceeds From Exercise Of Pre Funded Warrants And Common Warrants | $42.3M | $3.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q4 2020 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $14.0K | $13.0K | $13.0K | $14.0K | $25.0K | $25.0K | $17.0K | $19.0K | $32.0K | $41.0K | $42.0K | $54.0K | $55.0K | $52.0K | $45.0K | $51.0K | ||
| Payments Of Stock Issuance Costs | $1.1M | $2.0K | $0.00 | $3.0M | $1.9M | $1.6M | $480.0K | |||||||||||
| Share Based Compensation | $5.2M | $435.0K | $91.0K | $302.0K | $271.0K | $38.0K | $55.0K | |||||||||||
| Net Cash Provided By Used In Operating Activities | -$3.4M | -$4.6M | -$4.6M | -$4.0M | -$4.3M | -$2.4M | -$545.0K | |||||||||||
| Increase Decrease In Lease Liabilities | -$32.0K | -$73.0K | -$67.0K | -$62.0K | -$52.0K | -$46.0K | -$27.0K | |||||||||||
| Increase Decrease In Employee Related Liabilities | $37.0K | $16.0K | -$4.0K | -$11.0K | -$8.0K | -$8.0K | $18.0K | |||||||||||
| Increase Decrease In Accounts And Other Receivables | -$30.0K | -$226.0K | $0.00 | $0.00 | -$27.0K | -$974.0K | ||||||||||||
| Net Cash Provided By Used In Investing Activities | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$173.0K | $1.0K | |||||||||||
| Net Cash Provided By Used In Financing Activities | $0.00 | $21.7M | $27.9M | $16.0M | $1.8M | |||||||||||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $173.0K | ||||||||||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $86.0K | -$95.0K | $45.0K | $501.0K | $236.0K | |||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$156.0K | -$100.0K | -$709.0K | -$220.0K | ||||||||||||||
| Proceeds From Issuance Of Common Stock | $18.8M | $12.9M | $2.3M | |||||||||||||||
| Increase Decrease In Other Operating Assets | -$220.0K | -$179.0K | -$374.0K | -$130.0K | ||||||||||||||
| Proceeds From Issuance Of Common Stock Pre Funded Warrants And Common Warrants | $30.9M | $17.9M | ||||||||||||||||
| Effect Of Exchange Rate On Cash And Cash Equivalents | $236.0K | $182.0K | -$313.0K | |||||||||||||||
| Proceeds From Exercise Of Pre Funded Warrants And Common Warrants | $0.00 | $21.7M | $30.9M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.05 | -$1.22 | -$14.12 | -$37.88 | -$3.23 | -$8.10 | $3.05 |
| Earnings Per Share Basic | $-1.05 | $-1.22 | $-14.12 | $-37.88 | $-3.23 | ||
| Common Stock Shares Outstanding | 25.5M | 23.5M | 1.7M | 480.7K | 8.2M | 1.1M | 856.8K |
| Common Stock Shares Issued | 25.5M | 23.5M | 10.1M | 480.7K | 8.2M | 1.1M | 856.8K |
| Weighted Average Number Of Shares Outstanding Basic | 36.2M | 18.4M | 1.4M | 480.7K | 4.3M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 36.2M | 18.4M | 1.4M | 480.7K | 4.3M | ||
| Common Stock Shares Authorized | 160.0M | 160.0M | 160.0M | 40.0M | 10.0M | 10.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 4.3M | 1.0M | 856.8K | ||||
| Preferred Stock Shares Authorized | 5.0M | ||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.26 | -$0.22 | -$0.21 | -$0.24 | -$0.26 | -$0.18 | -$0.23 | -$2.64 | -$3.05 | -$2.67 | -$3.34 | -$7.98 | -$0.40 | -$0.59 | -$0.62 | -$0.82 | -$0.76 | -$2.45 | -$1.96 | -$2.00 | -$1.34 |
| Earnings Per Share Basic | $-0.26 | $-0.22 | $-0.21 | $-0.24 | $-0.26 | $-0.18 | $-0.23 | $-2.64 | $-3.05 | $-2.67 | $-3.34 | $-7.98 | $-0.40 | $-0.59 | $-0.62 | ||||||
| Common Stock Shares Outstanding | 34.3M | 26.3M | 26.3M | 17.9M | 2.7M | 2.6M | 2.5M | 28.0M | 28.0M | 25.8M | 8.2M | 8.2M | 8.2M | 4.8M | 4.5M | 1.1M | |||||
| Common Stock Shares Issued | 34.3M | 26.3M | 26.3M | 17.9M | 2.7M | 2.6M | 2.5M | 28.0M | 28.0M | 25.8M | 8.2M | 8.2M | 8.2M | 4.8M | 4.5M | 1.1M | |||||
| Weighted Average Number Of Shares Outstanding Basic | 46.0M | 41.5M | 41.2M | 38.6M | 37.3M | 27.9M | 18.3M | 2.6M | 2.2M | 1.6M | 1.6M | 638.6K | 8.2M | 8.2M | 8.2M | ||||||
| Weighted Average Number Of Diluted Shares Outstanding | 46.0M | 41.5M | 41.2M | 38.6M | 37.3M | 27.9M | 18.3M | 2.6M | 2.2M | 1.6M | 1.6M | 638.6K | 8.2M | 8.2M | 8.2M | ||||||
| Common Stock Shares Authorized | 160.0M | 160.0M | 160.0M | 160.0M | 160.0M | 160.0M | 160.0M | 160.0M | 160.0M | 160.0M | 40.0M | 40.0M | 40.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 8.2M | 8.2M | 8.2M | 4.7M | 4.3M | 1.1M | 1.1M | 1.0M | 858.8K | ||||||||||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | ||||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $17.4M | $830.0K | $452.0K | $870.0K | $634.0K | $237.0K | $672.0K |
| Foreign Currency Transaction Gain Loss Before Tax | -$71.0K | $40.0K | -$415.0K | -$232.0K | -$333.0K | -$88.0K | -$75.0K |
| Royalties And License Fees | $0.00 | -$108.0K | $0.00 | $9.0K | $123.0K | -$185.0K | $435.0K |
| Stock Issued During Period Value New Issues | $39.3M | $2.8M | $22.5M | $1.7M | |||
| Stock Issued During Period Value Stock Options Exercised | $3.0M | $190.0K | |||||
| Issuance And Exercise Of Prefunded And Common Warrants Net Of Transaction Costs | $27.9M | $16.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $7.4M | $5.2M | $2.6M | $3.1M | $435.0K | $192.0K | $93.0K | $91.0K | $71.0K | -$48.0K | $302.0K | $192.0K | $239.0K | $271.0K | $235.0K | $82.0K | $38.0K | $88.0K | $37.0K | $55.0K | |
| Foreign Currency Transaction Gain Loss Before Tax | $131.0K | -$89.0K | $119.0K | $11.0K | -$294.0K | $93.0K | -$118.0K | $152.0K | -$56.0K | -$45.0K | $161.0K | -$507.0K | $229.0K | $48.0K | -$240.0K | -$112.0K | $0.00 | -$54.0K | -$7.0K | $5.0K | $0.00 |
| Royalties And License Fees | $0.00 | $0.00 | $0.00 | $0.00 | -$3.0K | $1.0K | -$106.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $7.0K | -$19.0K | $134.0K | $47.0K | -$306.0K | $26.0K | ||
| Stock Issued During Period Value New Issues | $201.0K | $16.6M | $20.0M | $1.7M | |||||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $123.0K | $1.2M | $1.7M | $39.0K | |||||||||||||||||
| Issuance And Exercise Of Prefunded And Common Warrants Net Of Transaction Costs | $28.2M | $27.9M | $16.0M |
Most recent annual filing with the SEC: September 22, 2025
Data sourced from SEC EDGAR public filings as of August 4, 2026.